Business
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
Full renewal of the Board of DirectorsElection of Dr. Markus Cappel as Chairman of the Board of Directors Nantes, September 30, 2025, 7:30 p.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) held its Annual General Meeting today in Paris and welcomed the participation of shareholders in this key moment for the company’s future. The shareholders who voted on the resolutions represented approximately 56% of OSE’s share capital and more than 62% of the voting rights. During this G
About this update from Ose Immunotherapeutics Sa
[{"type":"image","alt":"OSE Immunotherapeutics","displaySize":"","headline":null,"caption":"OSE Immunotherapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":100,"url":"https://media.zenfs.com/en/globenewswire.com/bca4e9e3611afcc1a4e99230a01fa8eb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/h55Oot7mWh39J7Yvj1GueA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bca4e9e3611afcc1a4e99230a01fa8eb","width":300,"height":100}},"lazy":false},{"type":"text","content":"Full renewal of the Board of DirectorsElection of Dr. Markus Cappel as Chairman of the Board of Directors","length":106,"tagName":"p"},{"type":"text","content":"Nantes, September 30, 2025, 7:30 p.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) held its Annual General Meeting today in Paris and welcomed the participation of shareholders in this key moment for the company’s future. The shareholders who voted on the resolutions represented approximately 56% of OSE’s share capital and more than 62% of the voting rights.","length":380,"tagName":"p"},{"type":"text","content":"During this General Meeting, shareholders notably voted in favor of the appointment of the following directors:","length":111,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Caroline Mary, as representative of employee shareholders.","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Pascale Briand, Markus Cappel, Jonathan Cool, Marc Le Bozec, Shihong Nicolaou","length":77,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":135,"olType":false},{"type":"text","content":"and Alexis Peyroles.","length":20,"tagName":"p"},{"type":"text","content":"Following the General Meeting, the new Board of Directors held its first meeting and elected Dr. Markus Cappel as Chairman.","length":123,"tagName":"p"},{"type":"text","content":""I am truly honored and enthusiastic to join OSE Immunotherapeutics' Board of Directors as Chairman. I look forward to working closely with the new Board and the talented OSE team to advance their promising pipeline and bring exciting, novel medicines to patients in need," said Dr. Markus Cappel, Chairman of the Board.","length":334,"tagName":"p"},{"type":"text","content":"“The excitement around OSE Immunotherapeutics stems from its strong pipe...